# Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI

Study · id `cardio:ct-nct04285736` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04285736](<https://clinicaltrials.gov/study/NCT04285736>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04285736

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT04285736. Randomized; no masking; primary purpose treatment. Start 2014-12 (actual); primary completion 2016-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT04285736, source copy `cardio:ctgov-nct04285736-2024-08-22`, retrieved 2026-10-26)
- Started: 2014-12 (actual) (ClinicalTrials.gov record NCT04285736, source copy `cardio:ctgov-nct04285736-2024-08-22`, retrieved 2026-10-26)
- Primary completion: 2016-05 (actual) (ClinicalTrials.gov record NCT04285736, source copy `cardio:ctgov-nct04285736-2024-08-22`, retrieved 2026-10-26)
- Completion: 2016-05 (actual) (ClinicalTrials.gov record NCT04285736, source copy `cardio:ctgov-nct04285736-2024-08-22`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04285736-2024-08-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI
- Condition: NSTEMI
- Intervention (Drug): Ivabradine
- Intervention (Drug): Conventional Treatment
- Lead sponsor: Cairo University
- Lead sponsor class: OTHER
- Collaborator: National Heart Institute, Egypt
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry lists this organization as the lead sponsor: Cairo University (`cardio:org-cairo-university`)
- Registry lists this organization as a collaborator: National Heart Institute, Egypt (`cardio:org-national-heart-institute-egypt`)

## Provenance

Content hash: 3115140c44adfecd748e140252523dc777297a981aceb37a4aa94765776377ab
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
